Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 21, 2020U.S. Orders 140 Million Additional Devices; Canada Orders 37 Million Additional Devices
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional pandemic orders for needles and syringes from the United States and Canada...
-
Jul 17, 2020
WARWICK, R.I. (July 17, 2020) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Kevin Kelly to worldwide...
-
Jul 15, 2020Government committed to use of BD Veritor™ Plus System and 15-minute SARS-CoV-2 test kits
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today a commitment from the U.S. Department of Health and Human Services (HHS) to purchase BD...
-
Jul 8, 2020Company Finalizes Initial Pandemic Order for 50 Million Injection Devices to Support Operation Warp Speed Vaccination Program
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced...
-
Jul 7, 2020New BD PurPrep™ skin preparation is the only commercially available PVP-I antiseptic skin preparation with sterile solution in the U.S.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of BD PurPrep™ patient preoperative skin preparation with sterile...
-
Jul 6, 2020- Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization...
-
Jul 3, 2020
CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), announced a voluntary recall for all CME America BodyGuard® Infusion System Administration Sets (infusion...
-
Jul 3, 2020First Shipments of Injection Devices Already Arrived in U.K.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the receipt of a large pandemic order from the U.K. government for 65 million needles...
-
Jul 2, 2020
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00...
-
Jun 16, 2020BD Vacutainer® UltraTouch™ Push Button Blood Collection Set with Preattached Holder enhances offerings that protect healthcare workers from needlestick injury
FRANKLIN LAKES, N.J., June 16, 2020 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it obtained the CE mark in Europe for the...